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Controlling responsiveness to prevailing signals is
critical for robust transitions between cell states
during development. For example, fibroblast growth
factor (FGF) drives naive pluripotent cells into extra-
embryonic lineages before implantation but sustains
pluripotency in primed cells of the post-implantation
epiblast. Nanog supports pluripotency in naive cells,
while Nodal supports pluripotency in primed cells,
but the handover from Nanog to Nodal does not
proceed seamlessly, opening up the risk of aberrant
differentiation if FGF is activated before Nodal. Here,
we report that Id1 acts as a sensor to detect delays in
Nodal activation after the downregulation of Nanog.
Id1 then suppresses FGF activity to delay differentia-
tion. Accordingly, Id1 is not required for naive or
primed pluripotency but rather stabilizes epiblast
identity during the transition between these states.
These findings help explain how development pro-
ceeds robustly in the face of imprecise signals and
highlight the importance of mechanisms that stabi-
lize cell identity during developmental transitions.
INTRODUCTION
Pluripotent cells in the early embryo choose their fate according
to the signals they receive from their local environment (Arnold
and Robertson, 2009). However, pluripotent cells are unlikely
to respond passively to prevailing signals. Rather, the ability to
respond to or ignore particular signals must be tightly coordi-
nated with changes in differentiation potential in order to ensure
that cell fate decisions are not misdirected by premature fluctu-
ations in pro-differentiation cues.
Control over signal responsiveness becomes particularly
important where the same signal is re-deployed to regulate
successive cell fate restrictions. For example, fibroblast growth
factor (FGF) drives naive pluripotent cells in the early embryo
to differentiate into extraembryonic cell types (Chazaud et al.,
2006; Hamilton and Brickman, 2014; Nichols et al., 2009; Yama-
naka et al., 2010), whereas FGF helps to sustain pluripotencyDevelopmental Cell 50, 1–16, A
This is an open access article undonce pluripotent cells have transitioned into a ‘‘primed’’ state (Ar-
nold and Robertson, 2009; Brons et al., 2007; Tesar et al., 2007).
Therefore, for this transition to proceed successfully, the shift in
FGF activity must somehow be timed to occur only after cells
irreversibly commit to the primed epiblast state.
Nodal protects pluripotency in the primed epiblast of the post-
implantation embryo (Camus et al., 2006; Mesnard et al., 2006)
while Nanog protects pluripotency in the naive epiblast of the
pre-implantation embryo (Mitsui et al., 2003). The handover be-
tween these two factors does not, however, appear to proceed
seamlessly: some Nanog-negative epiblast cells lack Nodal ac-
tivity in the late pre-implantation embryo (Granier et al., 2011).
With neither Nanog nor Nodal available to sustain epiblast iden-
tity, these transiting epiblast cells would be in a precarious state,
unless some other factor comes into play to protect them against
the pro-endoderm effects of autocrine FGF (Chazaud et al.,
2006; Hamilton and Brickman, 2014; Nichols et al., 2009; Yama-
naka et al., 2010). This putative factor should have three key
properties: the ability to sense low levels of Nodal activity, the
ability to dampen FGF responsiveness, and the ability to protect
pluripotent cells from differentiation.
A likely candidate is the BMP (Bone Morphogenic Protein)
target gene Id1. Id1 is sensitive to Nodal activity (Galvin et al.,
2010) and is able to prevent differentiation of pluripotent cells
(Ying et al., 2003; Zhang et al., 2010), but the details of when
and how it operates remain unclear. It has been proposed that
Id1 supports naive pluripotency by maintaining high levels of
Nanog (Galvin-Burgess et al., 2013; Romero-Lanman et al.,
2012; Ying et al., 2003). However, surprisingly, we report here
that Id1 protein is absent from the embryonic day (E) 3.5 embryo
and is only expressed in cells that have lost Nanog expression
during peri-implantation development. This seems incompatible
with the idea that BMP-Id1 maintains naive pluripotency but is
consistent with idea that Id1 comes into play to protect epiblast
identity after downregulation of Nanog.
Here, we report that Id1 stabilizes an epiblast identity specif-
ically during the transition between naive and primed states.
Id1 acts as a ‘‘sensor’’ to detect when cells have lost Nanog
expression but have not yet acquired Nodal activity. Id1 then
suppresses FGF in order to protect these cells from aberrant
differentiation. Once a Nodal-responsive post-implantation
epiblast state has been achieved, Nodal suppresses Id1 expres-
sion and so permits FGF activity to rise to help sustain pluripo-
tency in newly configured primed epiblast cells.ugust 19, 2019 ª 2019 The Author(s). Published by Elsevier Inc. 1
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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Figure 1. Pluripotent Cells Remain Resistant to BMP Signaling until Peri-implantation Stages of Development
(A) Immunofluorescent staining of E3.5 blastocyst for Nanog and the BMP target Id1.
(B) Immunofluorescent staining of late E4.5 blastocyst for Id1 and Nanog.
(C) Immunofluorescent Id1 staining of ESCs cultured in 2i + LIF, unstimulated or stimulated with 10 ng/mL BMP4 for 48 h.
(D) Flow cytometry analysis of Id1-Venus reporter ESCs cultured in 2i + LIF, unstimulated or stimulated with 10 ng/mL of BMP4 for 48 h.
(E) Immunofluorescent Id1 staining of ESCs cultured in LIF + FCS, unstimulated or stimulated with 10 ng/mL of BMP4 for 48 h.
(F) Flow cytometry analysis of Id1-Venus reporter ESCs cultured in LIF + FCS, unstimulated or stimulated with 10 ng/mL of BMP4 for 48 h.
(G) Immunofluorescent staining of E5.5 embryo for Id1 and Nanog.
(H) Immunofluorescent Id1 staining of EpiSCs, unstimulated or stimulated with 10 ng/mL of BMP4 for 48 h.
(I) Flow cytometry analysis of Id1-Venus reporter EpiSCs, unstimulated or stimulated with 10 ng/mL of BMP4 for 48 h.
(legend continued on next page)
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RESULTS
Pluripotent Cells Remain Resistant to BMP Signaling
until Peri-implantation Development
We examined whether pluripotent cells modulate responsive-
ness to prevailing signals as they proceed toward differentiation.
We focused on BMP signaling because BMP suppresses differ-
entiation of pluripotent cells in culture (Ying et al., 2003) and
in vivo (Di-Gregorio et al., 2007). The BMP target gene Id1
(Hollnagel et al., 1999) recapitulates the effects of BMP on plurip-
otent cells (Malaguti et al., 2013; Ying et al., 2003; Zhang et al.,
2010) and provides a biologically relevant readout of BMP activ-
ity (Figures S1A–S1C).
Bmp4/7 and pSmad1 are readily detectable in pre-implanta-
tion embryos at E3.5 (Coucouvanis and Martin, 1999; Graham
et al., 2014). However, to our surprise, we were unable to detect
the product of the direct BMP target gene Id1 in E3.5 embryos
(Figure 1A) or in early E4.5 embryos (data not shown). We
then examined embryos after E4.5, at the latest stage obtainable
before the embryo implants. These embryos contain a sub-
population of Id1+ cells scattered throughout the epiblast in a
salt-and-pepper distribution (Figure 1B). This suggests that
patterning of Id1 is unlikely to be explained only by exposure
to exogenous BMP ligands (because these ligands are diffusible
and so unlikely to adopt a salt-and-pepper distribution) and
instead might reflect cell-cell variability in BMP responsiveness.
In order to test this, we examined pluripotent cells in culture,
where we could stimulate cells with BMP4. We first examined
cells in 2i + LIF culture, which supports a stage of pluripotency
equivalent to that of the early E4.5 blastocyst (Boroviak et al.,
2015). We were unable to detect Id1 protein even after stimu-
lating 2i + LIF cells with high doses (10 ng/mL) of BMP4 (Fig-
ure 1C). These findings were confirmed using cells in which an
Id1-Venus fusion was expressed from the Id1 locus (Figures
1D and S1D–S1G) (Malaguti et al., 2013; Nam and Ben-
ezra, 2009).
We then examined embryonic stem cells (ESCs) in LIF
(leukemia inhibitory factor) + fetal calf serum (FCS), a culture
condition that supports a mixture of naive and primed cells
(Nichols and Smith, 2009). We could detect Id1 protein in
some cells, although a subpopulation remained Id1 negative
even when stimulated with BMP4 (Figures 1E and 1F), in keep-
ing with reports that naive cells do not activate Id1 in response
to BMP (Gomes Fernandes et al., 2016).
We then examined post-implantation embryos and epiblast
stem cells (EpiSCs) (Brons et al., 2007; Tesar et al., 2007). As ex-
pected, the E5.5 epiblast expresses Id1 in cells close to the
extraembryonic ectoderm, a source of BMP signals (Arnold
and Robertson, 2009) (Figures 1G and S1H). EpiSC stimulated(J) Immunofluorescent staining of ESCs cultured in LIF + FCS for Id1 and Nanog
(K) Quantification of Id1 and Nanog immunofluorescent signal in single ESCs cu
(L) Diagram illustrating how BMP sensitivity increases around the time of implan
Scale bars, 30 mm.
See also Figure S1.with BMP4 express moderate levels of Id1 in a minor subset of
cells (Figures 1H and 1I), indicating that BMP responsiveness de-
creases as pluripotent cells reach a primed state. This transient
window of Id1 expression at the onset of the transition between
naive and primed pluripotency can be recapitulated in vitro in
epiblast-like cell (EpiLC) differentiation (Figure S1J).
Some epiblast cells in the late E4.5 embryo downregulate the
naive determinant Nanog to prepare for the transition to a primed
state (Xenopoulos et al., 2015). We detect Id1 exclusively within
these Nanog-low cells (Figure 1B). Similarly, Id1 is expressed
predominantly in Nanog-low cells in LIF + FCS (Figures 1J
and 1K).
We conclude that pluripotent cells modulate responsiveness
to BMP4 over time. They become most responsive as they enter
a transition phase between naive and primed pluripotency, cor-
responding to a stage of peri-implantation development after
downregulation of Nanog but before establishment of a primed
pluripotent state (Figure 1L).
Id1 Predicts the Probability of Differentiating after
Downregulation of Nanog
It is surprising that Id1, which maintains pluripotency of ESCs
(Ying and Smith, 2003; Zhang et al., 2010), is not expressed in
Nanog-high cells in vivo or in culture (Figures 1B, 1J, and 1K).
Could it instead be protecting epiblast identity during the transi-
tion from naive to primed states?
The transition to a primed state is initiated by downregulation
of Nanog in concert with other components of the naive gene
regulatory network (GRN) (Kalkan et al., 2017). However, loss
of Nanog does not commit cells to undergo this transition:
some Nanog-low cells resist differentiation and revert back to
a Nanog-high state (Chambers et al., 2007; Kalmar et al.,
2009). We asked whether Id1 identifies those cells that resist dif-
ferentiation after loss of Nanog.
We generated a dual-reporter ESC line, which expresses an
Id1-Venus fusion protein from the endogenous Id1 locus (Mala-
guti et al., 2013; Nam and Benezra, 2009), and a Nanog-tagRFP
fusion protein from the endogenousNanog locus (Figures 2A and
S2A–S2E). We first confirmed that Nanog and Id1 tend to mark
different subpopulations in LIF + FCS (Figure 2B).We then sorted
three populations of cells from LIF + FCS: Nanog-high (NR-HI
IdV-LO), Id1-high Nanog-low (IdV-HI NR-LO), and Id1-low
Nanog-low cells (IdV-LO NR-LO) (Figures 2C and S2F).
As expected (Festuccia et al., 2012), transcriptomes differed
between Nanog-high cells and Nanog-low cells. In contrast,
within the Nanog-low compartment, transcriptomes of Id1-high
and Id1-low cells were almost indistinguishable (Figures 2D
and 2E; Table S1).
Id1 is not a transcriptional regulator: it acts by controlling the
activity of a range of proteins (Norton, 2000; Roberts et al.,
2001; Yates et al., 1999), so it seemed plausible that Id1-high
cells may be more resistant to differentiation than Id1-low cells
despite their similar transcriptomes..
ltured in LIF + FCS.
tation, as Nanog is being lost, and decreases following implantation.
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entiation. We challenged cells with differentiation medium
(N2B27) for 6 h and then returned them to self-renewal condi-
tions at clonal density to assess how many cells remained
undifferentiated. We also plated sorted cells directly into self-
renewal conditions at clonal density to measure the number of
undifferentiated cells in each starting population. We combined
these data to establish the proportion of undifferentiated cells
that resist differentiation during the 6 h challenge (Figure 2F).
This reveals that Id1-high cells resist differentiation
more effectively than Id1-low cells: the majority (62% ± 6%) of
IdV-HI NR-LO cells resisted differentiation, as did the majority
(69% ± 15%) of NR-HI IdV-LO cells. Only a minority (39% ±
5%) of IdV-LO NR-LO cells were able to resist differentiation
(Figure 2G).
Although there is low residual expression of Nanog and other
naive pluripotency transcription factors within our ‘‘Nanog-low’’
sorted subpopulations (Figures S2F and S2G), this cannot
explain our findings because there was no difference in expres-
sion of these factors between Id1-high and Id1-low cells (Figures
S2G and S2H), nor was there any difference in the number of
colony-forming cells prior to the differentiation challenge (Fig-
ure S2I), indicating that there are no functional differences in
naive transcription factor activity between the two populations.
We conclude that Id1 identifies a subpopulation of Nanog-low
cells that resist differentiation independently of the activity of the
naive pluripotency GRN.
Id1 Protects Pluripotent Cells fromDifferentiation in the
Absence of Nanog
Having seen that Id1 correlates with resistance to differentiation
after downregulation of Nanog, we asked whether Id1 is capable
of suppressing differentiation after downregulation of Nanog.We
made use of an ESC line containing a doxycycline-inducible Id1Figure 2. Id1 Protects Pluripotent Cells from Differentiation in the Abs
(A) Diagrammatic structure of Id1-Venus Nanog-tagRFP double reporter ESCs.
(B) Flow cytometry of Id1-Venus Nanog-tagRFP cells cultured in LIF + FCS confir
cells. Gates used for sorting experiments are displayed.
(C) Sorting strategy for downstream transcriptome analysis of LIF + FCS culture
(D) PCA of the sorted subpopulations, 2i and 2i + LIF cultures.
(E) Pairwise transcriptomic comparisons of the three sorted subpopulations.
(F) Experimental strategy. Id1-Venus Nanog-tagRFP ESCs cultured in LIF + FCS w
colonies when plated at clonal density immediately after sorting and after 6-h N2
(G) Proportion of cells capable of resisting differentiation after 6-h N2B27 culture
FCS, divided by number of AP+ colonies obtained after replating cells in LIF + F
represented as mean ± SEM of three independent experiments.
(H) Experimental strategy for Id1 gain-of-function experiment. ESCs carrying a d
N2B27 for 24 h, in the presence or absence of 1mg/mL doxycycline. The cells were
LIF + FCS.
(I) Number of AP+ colonies obtained after replating cells as described in (H). Platin
of five independent experiments.
(J) Diagram of rescue of Nanog⁄ cells. Clonal cell lines were generated to stab
(K) Number of undifferentiated AP+ colonies obtained upon plating Nanog-rescue
100 cells/well of a 6-well plate.
(L) Immunofluorescent staining of Nanog-rescue cells cultured in LIF + FCS for G
(M) qRT-PCR analysis of Nanog-rescue cells cultured in LIF + FCS. Each shape
Statistical analyses: for comparison of two samples: two-tailed unpaired Student’
multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001.
NR, Nanog-tagRFP; IdV, Id1-Venus; HI, high; LO, low; AP, alkaline phosphatase
See also Figure S2 and Table S1.transgene (Malaguti et al., 2013). We placed these cells in N2B27
for 24 h, a time frame that is sufficient to downregulate members
of the naiveGRN (Kalkan et al., 2017), in the presence or absence
of doxycycline.We then replated the cells clonally in self-renewal
conditions (Figure 2H). We find that forced expression of Id1
during this time window in which the naive GRN is dismantled
increases the number of cells that resist differentiation
(Figure 2I).
If Id1 protects pluripotent cells from differentiation in the
absence of Nanog, then it should be able to rescue the sponta-
neous differentiation phenotype of Nanog-null cells in LIF + FCS
(Chambers et al., 2007). Forced expression of Id1 restores the
colony-forming ability of Nanog-null cells to a similar extent to
forced expression of Nanog itself (Figures 2J and 2K) and re-
duces the expression of markers of primitive endoderm (Gata4,
Gata6, and Sox17) and primed epiblast (Fgf5 and Oct6, also
known as Pou3f1) (Figures 2L and 2M).
These data suggest that Id1 is responsible for protecting
pluripotent cells from differentiation after downregulation
of Nanog.
A Coordinated Shift in BMP and FGF and Nodal
Responsiveness after Downregulation of Nanog
We looked for transcriptional changes that might explain why
IdV-LO NR-LO cells are more susceptible to differentiation
than IdV-HI NR-LO cells.
Compared with IdV-HI NR-LO cells, only six protein-coding
genes were enriched in IdV-LO NR-LO cells (Figures 3A and
3B). Only two of these, Egr1 and Lefty1, were confirmed by
qRT-PCR to be differentially expressed (Figures 3C and S3A).
Egr1 and Lefty1 are readouts of the FGF and Nodal signaling
pathways, respectively, and these are the two pathways that
sustain pluripotency in primed pluripotent cells (Brons et al.,
2007; Camus et al., 2006; Tesar et al., 2007). We confirmedence of Nanog
m that high levels of Id1 expression are observed predominantly in Nanog-low
s.
ere sorted into three subpopulations then assayed for their ability to form AP+
B27 culture.
. Number of AP+ colonies obtained after replating 6-h N2B27 cultures in LIF +
CS immediately after sorting. Plating density: 1,000 cells/9 cm dish. Data are
oxycycline-inducible Id1 transgene were transferred from LIF + FCS culture to
assayed for their ability to form AP+ colonies when replated at clonal density in
g density: 100 cells/well of a 6-well plate. Data are represented as mean ± SEM
ly express Nanog (positive control), Id1, or GFP (negative control).
cells in LIF + FCS. Each shape represents a different clonal line. Plating density:
ata6 and LaminB1. Scale bar, 30 mm.
represents a different clonal line.
s t test; for comparison of three samples: one-way ANOVA followed by Tukey’s
; dox, doxycycline; Tg, transgene.
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Nodal target gene Lefty2, is also enriched in IdV-LO NR-LO cells
(Figure 3C). Id1 rescue of Nanog-null cells also correlates with
reduced expression of Egr1 (Figure S3B).
The FGF target gene Egr1 (although not the Nodal targets
genes Lefty1 or Lefty2) remained enriched in Id1-low cells after
a 6 h challenge with differentiation media, which is the time at
which Id1-high cells display their relative resistance to differenti-
ation (Figure 3D). Intriguingly, we do not observe differences in
expression of naive or primed pluripotency markers between
IdV-LO NR-LO and IdV-HI NR-LO cells at this time point (Figures
S3C and S3D), suggesting that differences in FGF sensitivity and
response can predict resistance to differentiation prior to overt
changes in pluripotency marker expression.
Having observed an increase in FGF target gene expression in
IdV-LONR-LO cells, we next asked whether these cells aremore
responsive to acute stimulation with exogenous Fgf2 than
Id1-high cells (Figure 3E). We find that a higher proportion of
IdV-LO NR-LO cells respond to Fgf2 stimulation by phosphory-
lating Erk1/2 (a direct readout of FGF activity) than Id1-high or
Nanog-high cells (Figures 3F and 3G).
These data suggest that there is a coordinated shift in signal
responsiveness within the Nanog-low compartment, with cells
becoming more responsive to FGF and Nodal signaling, as
they lose Id1 expression. It is the increase in FGF responsiveness
that best correlates with a higher probability of differentiating
(model shown in Figure 3H).
Id1 Is Responsible for Suppressing Differentiation
within the Nanog-Low Compartment
We next asked how differentiation is suppressed within Id1-high
cells. Eight genes are enriched in Id1-high cells (Figure S4),
including Id1 itself. Id1 has previously been reported to block
differentiation of naive and primed pluripotent cells (Aloia et al.,
2015; Malaguti et al., 2013; Romero-Lanman et al., 2012; Ying
et al., 2003; Zhang et al., 2010), but a role during the transition
between these two states has not been explored.
Id1-null ESCs have impaired clonogenic potential and display
reduced levels of Nanog and increased levels of the primed plu-
ripotency marker Oct6 (Figures 4A–4C). These phenotypes canFigure 3. A Coordinated Shift in BMP, FGF, and Nodal Responsivenes
(A) Experimental strategy. ESCs cultured in LIF + FCS were sorted into three sub
gene expression analysis immediately after sorting and after 6 h culture in N2B2
(B) Heatmap of transcripts significantly enriched in NR-LO IdV-LO relative to NR-L
p value adjusted for multiple testing correction < 0.5.
(C) qRT-PCR analysis of sorted subpopulations before the 6-h N2B27 differenti
experiments.
(D) qRT-PCR analysis of sorted subpopulations after the 6-h N2B27 differentiati
periments.
(E) Experimental strategy for acute Fgf stimulation of sorted subpopulations. Follo
cytospun and stained for pErk1/2 expression.
(F) Immunofluorescent staining of sorted subpopulations for pErk1/2. Scale bar,
(G) Percentage of pErk1/2-positive cells following 1 h Fgf2 stimulation of sorted su
(F). Samples from the same sort are indicated with the same shape.
(H)Model: once Nanog is lost from pluripotent cells, Id1 expression is associatedw
targets.
Statistical analyses of qRT-PCR and QIF data were performed using a one-way AN
0.001. Methods for statistical analysis of transcriptomic data are described in th
NR, Nanog-tagRFP; IdV, Id1-Venus; HI, high; LO, low, Meki: Mek inhibitor (1 mM
Figure S3 and Table S1.be rescued by placing cells into 2i + LIF culture conditions in or-
der to maintain uniform high levels of Nanog (Figures 4D–4F) or
by addition of a Mek inhibitor (PD0325901) to LIF + FCS cultures
in order to suppress FGF activity (Figures 4G–4I).
These data suggest that Id1 is dispensable within naive
(Nanog-high) pluripotent cells but that it protects cells from
differentiating after downregulation of Nanog.
Id1 Dampens FGF Responsiveness
We next asked whether Id1 is responsible for suppressing FGF
activity. Id1-null cells display increased expression of the FGF
target gene Egr1, and this can be reversed by restoring Id1
expression (Figures 5A–5C). Nodal activity is also dampened in
Id1-high cells (Figures 3B and 3C), but Id1-null cells do not
have increased expression of the Nodal target gene Lefty1 (Fig-
ure 5D), suggesting that Nodal signaling may regulate, rather
than be regulated by, Id1 expression.
Egr1 is not only a passive readout of FGF activity; it also me-
diates the effects of FGF on pluripotent cells (Galonska et al.,
2015). Egr1 is correlated with and controlled by Id1 in our exper-
iments (Figures 3B–3D, 5A–5C, and S3B), so we asked how Id1
regulates Egr1.
E2A homodimers directly regulate Egr1 in pro-B cells (Lin
et al., 2010), and E2A activity is repressed by Id1 (Massari
and Murre, 2000). We therefore first considered E2A as a likely
candidate for mediating the effects of Id1 on Egr1. However,
this does not seem to be the case: Egr1 does not respond to
experimental activation of E2A homodimers in ESCs (Figures
S5A and S5B).
We have previously identified Tcf15 as an Id-regulated pro-dif-
ferentiation factor in ESCs (Davies et al., 2013). Transcriptome
analysis of Tcf15-responsive genes indicates that Tcf15 upregu-
lates Egr1 (Davies et al., 2013). Using Tcf15-null cells, we find
that Tcf15 is required for maximal Egr1 expression after downre-
gulation of Nanog (Figures 5E and 5F). These data are consistent
with the idea that Id1 suppresses Egr1 expression through sup-
pression of Tcf15 activity.
Taken together, our data suggest that Id1 orchestrates
a coordinated shift in growth factor responsiveness and
differentiation.s after Downregulation of Nanog
populations based on Id1-Venus and Nanog-tagRFP. Samples were taken for
7 differentiation medium.
O IdV-HI subpopulations. Significance was defined as log2(fold-change) > 0.5,
ation challenge. Data are represented as mean ± SEM of seven independent
on challenge. Data are represented as mean ± SEM of three independent ex-
wing sorting, cells were cultured in N2B27+10 ng/mL Fgf2 in suspension, then
30 mm.
bpopulations, calculated by quantitative immunofluorescence of cells shown in
ith resistance to differentiation and lower expression of Fgf andNodal signaling
OVA followed by Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p <
e STAR Methods section.
PD0325901); QIF, quantitative immunofluorescence; +ve, positive. See also
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We report above that there is a transient peak of Id1 protein
expression during the transition from naive to primed epiblast
states resulting from changes in ‘‘responsiveness’’ to BMP
rather than changes in ‘‘exposure’’ to BMP (Figures 1C–1F, 1H,
and 1I). We asked what is responsible for suppressing Id1 in
naive cells.
Nanog is able to repress Id1 expression (Figures S6A and S6B;
Festuccia et al., 2012; Suzuki et al., 2006) and Id1 is derepressed
in Nanog-null cells (Figures 6A and 6B). We examined Nanog-
null ESCs in which the naive subpopulation can be identified
via a fluorescent reporter targeted to the Nanog locus (Cham-
bers et al., 2007). This confirmed that there is an overall increase
in Id1 expression, although Id1 remains repressed in a subset of
Nanog-null cells (Figures 6C and 6D). We conclude that Nanog
contributes to, but is not solely responsible for, repression of Id1.
Nodal signaling is also able to repress Id1 expression (Galvin
et al., 2010; Galvin-Burgess et al., 2013). The Nodal target
gene Lefty1 is enriched in Id1-low cells in LIF + FCS (Figures
3B and 3C) yet is not affected in Id1-null cells (Figure 5D), sup-
porting the idea that Nodal signaling acts upstream rather than
downstream of Id1.
In 2i + LIF, BMP4 is usually unable to upregulate Id1 (Figures
1C and 1D), but after addition of the Nodal inhibitor SB431542,
almost all cells switch on Id1 in response to BMP4 (Figures
6E–6G). Similarly, in LIF + FCS cultures, SB431542 derepresses
Id1, with the strongest increase observed within the Nanog-low
subpopulation (Figures 6H–6J). SB431542 also permits BMP4-
induced Id1 expression in EpiSCs (Figures 6K–6M). In keeping
with these observations, treatment of 2i + LIF and LIF + FCS cul-
tures with the Nodal agonist Activin A inhibits Id1 induction by
BMP4 (Figures S6C and S6D). These data suggest that Nodal
is the primary factor responsible for dampening Id1 expression
in primed cells.
We conclude that Nanog and Nodal repress Id1 within naive
cells and that Nodal also dampens Id1 expression within primed
cells. This explains how Id1 can act as a ‘‘sensor’’ of Nodal activ-
ity after downregulation of Nanog (Figure 6N).
Id1 Is Required for a Robust Transition from a Naive to a
Primed Epiblast State In Vivo
Our findings suggest that Id1 protects epiblast cells from pro-dif-
ferentiation cues from the time they lose Nanog expression
through to the time that Nodal signaling begins to sustain them
in a primed state.Figure 4. Id1 Is Responsible for Suppressing Differentiation within the
(A) Clonal self-renewal assays of wild-type, Id1-null, and Id1-rescue (Id1-null cel
(B) Immunofluorescent staining of wild-type, Id1-null, and Id1-rescue ESCs cultu
(C) Quantification of the IF data in (B).
(D) Clonal self-renewal assays of wild-type, Id1-null and Id1-rescue ESCs culture
(E) Immunofluorescent staining of wild-type, Id1-null, and Id1-rescue ESCs cultu
(F) Quantification of the IF data in (E).
(G) Clonal self-renewal assays of wild-type, Id1-null, and Id1-rescue ESCs cultur
(H) Immunofluorescent staining of wild-type, Id1-null, and Id1-rescue ESCs cultu
(I) Quantification of the IF data in (H).
All data are represented as mean ± standard deviation of three independent expe
by Tukey’s multiple comparison test. **p < 0.01. Plating density was 100 cells/w
between (A), (D), and (G). Immunofluorescence scale bars: 30 mm. See also FiguIn keeping with this model, Id1 is dispensable under optimized
differentiation conditions in vitro, where inappropriate pro-differ-
entiation signals are eliminated (Figure S7A). We predict that Id1
should become important under sup-optimal signaling condi-
tions such as those in the peri-implantation embryo where, for
example, Nodal becomes activated in only a subset of Nanog-
low cells (Granier et al., 2011). We devised an in vitro assay to
mimic these conditions. We cultured pluripotent cells in basal
media (N2B27) in order to allow cells to initiate exit from naive
pluripotency in the absence of exogenous cues. After 48 h, we
provided cells with low levels (1 ng/mL) of the Nodal agonist
Activin A to approximate the incomplete activation of Nodal
in vivo (Figure 7A). We used Oct4 (Pou5f1) to indicate the ability
of these cells to retain an epiblast identity.
When this assay is carried out in the absence of BMP, only
around half of cells retained Oct4 expression (Figures 7B–7D
and S7B: note bimodal distribution of Oct4 in Figures 7C and
S7B). Exposing cells to BMP in order to activate Id1 during the
first 48 h increased the robustness with which cells progress
through this transition, with the majority of cells maintaining
Oct4 expression (Figures 7B–7D and S7B: note unimodal distri-
bution of Oct4 in Figures 7C and S7B).
These results go some way toward supporting the hypothesis
that BMP-Id1 helps to protect pluripotent cells from suboptimal
signaling conditions. However, our in vitro assay falls far short of
capturing the complexities of the dynamic signaling environment
of the peri-implantation embryo.We therefore turned to an in vivo
assay system.
We examined the efficiency with which Id1-null cells can
persist throughout implantation and contribute to the post-im-
plantation epiblast in aggregation chimeras (Figure 7E). Cells,
which differentiate aberrantly or activate FGF prematurely during
this process, are eliminated by cell competition (Claverı´a et al.,
2013; Dı´az-Dı´az et al., 2017; Sancho et al., 2013).
Id1-null cells are able to contribute to the post-implantation
epiblast: 57% of embryos contained at least some Id1-null
ESCs, which is comparable to results from wild-type cells
(67% of embryos) and Id1-rescue cells (54% of embryos) (Fig-
ures 7F and 7G). However, the degree of contribution was lower
for Id1-null cells (30% high contribution) than wild-type (74%
high contribution) or Id1-rescue cells (53% high contribution)
(Figures 7F and 7G). Quantifying the number of ESCs that
contribute to the post-implantation epiblast confirmed that Id1-
null cells contribute to the epiblast less robustly than wild-type
or Id1-rescue cells (Figures 7F–7H).Nanog-Low Compartment
ls stably expressing an Id1 transgene) ESCs cultured in LIF + FCS.
red in LIF + FCS for Nanog, Oct4, and Oct6.
d in 2i + LIF.
red in 2i + LIF for Nanog, Oct4, and Oct6.
ed in LIF + FCS + 1 mM PD0325901 (a Mek inhibitor).
red in LIF + FCS + 1 mM PD0325901 for Nanog, Oct4, and Oct6.
riments. Statistical analyses were performed using a one-way ANOVA followed
ell of a 6-well plate for clonal assays. Note that the height of the y axes differs
re S4.
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Figure 5. Id1 Dampens FGF Responsiveness by Modulating the Activity of Tcf15
(A) Immunofluorescent staining for Egr1 and LaminB1 in wild-type, Id1-null, Id1-rescue ESCs cultured in LIF + FCS. Wild-type cells cultured in LIF + FCS + 1 mM
PD0325901 (+Meki) are included as a negative control. Scale bar, 30 mm.
(B) Quantification of the IF data in (A).
(C) qRT-PCR for the Fgf target Egr1 in wild-type, Id1-null, and Id1-rescue ESCs cultured in LIF + FCS.
(D) qRT-PCR for the Nodal target Lefty1 in wild-type, Id1-null, and Id1-rescue ESCs cultured in LIF + FCS.
(E) qRT-PCR for Tcf15 in wild-type and two Tcf15-null clonal cell lines during 2i + LIF to EpiLC differentiation.
(F) qRT-PCR for Egr1 in the samples described in (E).
Data are presented as mean ± standard deviation of three independent experiments. Statistical analyses were performed using a one-way ANOVA followed by
Tukey’s multiple comparison test. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S5.
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Differentiation, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.05.032In contrast, Id1-null ESCs contribute efficiently to the pre-im-
plantation pluripotent epiblast, displaying no sign of premature
differentiation or cell death (Figures S7C–S7E). This confirms
that Id1 is not required in naive pluripotent cells but becomes
important during peri-implantation development.
We conclude that Id1 is required for a robust transition from
the pre-implantation to the post-implantation epiblast in vivo.10 Developmental Cell 50, 1–16, August 19, 2019DISCUSSION
Coordinating Signaling with Differentiation during
Transitions between Cell States
There has been much progress in understanding the signals and
transcription factors that maintain naive and primed pluripotent
cell states (Betschinger et al., 2013; Buecker et al., 2014;
A B C D
GFE
H I J
K L M
N
Figure 6. Dynamic Regulation of Id1 Expression during the Transition from Naive to Primed States
(A) qRT-PCR for Id1 in wild-type and Nanog-null ESCs cultured in LIF + FCS. Data are represented as mean ± standard deviation of three independent ex-
periments.
(B) Median Id1 protein expression following immunofluorescence quantification of Id1 staining in wild-type and Nanog-null ESCs cultured in LIF + FCS. Data are
represented as mean ± standard deviation of three independent experiments.
(C) Immunofluorescence for Id1 and Nanog or GFP in wild-type ESCs and in Nanog-null ESCs harboring a GFP transgene under the control of the Nanog
promoter.
(D) Quantification of Id1 and Nanog or GFP immunofluorescent signal in single wild-type or Nanog-null ESCs cultured in LIF + FCS.
(E) Flow cytometry analysis of Id1-Venus ESCs cultured in 2i + LIF with or without stimulation with 10 ng/mL BMP4 and/or 10 mMof the Nodal inhibitor SB431542
for 48 h.
(F) Immunofluorescence for Id1 and Nanog in wild-type ESCs cultured in 2i + LIF with or without 48 -h stimulation with 10 ng/mL BMP4 and 10 mM SB431542.
(G) Quantification of immunofluorescence signal for the cells in (F).
(H) Flow cytometry analysis of Id1-Venus ESCs cultured in LIF + FCS with or without 48-h stimulation with 10 ng/mL BMP4 and/or 10 mM SB431542.
(I) Immunofluorescence for Id1 and Nanog in wild-type ESCs cultured in LIF + FCS with or without 48-h stimulation with 10 ng/mL BMP4 and 10 mM SB431542.
(J) Quantification of immunofluorescence signal for the cells in (I). Id1 is enriched in Nanog-low cells.
(legend continued on next page)
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less is known about how pluripotency is protected during the
transition between these states. We propose that cells regulate
changes in signal responsiveness in order to protect pluripo-
tency during this transition and that Id1 coordinates this process.
In the absence of Id1, cells fail to transit robustly from pre-
implantation to post-implantation stages of development.
Cells modulate signal responsiveness as they exit pluripo-
tency (Kalkan et al., 2017; Zhou et al., 2013) and it has
been proposed that prior to differentiation pluripotent cells
enter a ‘‘transition state’’ or ‘‘formative’’ state in which they
become more responsive to prevailing cues (Rue´ and Marti-
nez Arias, 2015; Smith, 2017), an idea that is supported by
our findings.
How Are Cells Protected from Differentiation after the
Collapse of the Naive GRN?
In culture, ESCs do not commit to a primed state immediately
after downregulating Nanog, but rather can reassemble a
naive GRN and revert to naive pluripotency (Chambers et al.,
2007; MacArthur et al., 2012). A proportion of Nanog-low
cells are nevertheless spontaneously lost to differentiation
(Chambers et al., 2007). Several lines of evidence suggest
that the decision of Nanog-low cells to regain Nanog or to
differentiate is stochastic (Abranches et al., 2014; Kalmar
et al., 2009; MacArthur et al., 2012). This might prompt the
assumption that no particular factor is brought into play to
determine the ability of cells to retain pluripotency and return
to a Nanog-high state.
However, the following observations from peri-implantation
embryos call this assumption into question: in peri-implanta-
tion embryos, in contrast to the situation in culture, cells that
lose Nanog after E4.5 neither return to a Nanog-high naive
state (Xenopoulos et al., 2015) nor differentiate into extraem-
bryonic endoderm (Grabarek et al., 2012). Rather, they are
efficiently captured into a post-implantation epiblast state
that is dependent on Nodal (Camus et al., 2006; Mesnard
et al., 2006). The existence of cells in the embryo that lack
both Nanog and Nodal activity points to the existence of
another factor that protects these cells from differentiation.
We propose that this factor is Id1.
Recent findings indicate that extraembryonic endoderm po-
tency is not irreversibly lost but rather remains latent in
epiblast cells during implantation (Nowotschin et al., 2019).
This implies the existence of mechanisms that protect the
epiblast from differentiating into extraembryonic endoderm
throughout the course of pregastrulation development. Nanog
performs this role in the E3.5 embryo (Mitsui et al., 2003), and
we now propose that Id1 takes over this role immediately after
downregulation of Nanog. In support of this idea, we find that
Id1 can protect Nanog-null cells from differentiating into prim-
itive endoderm.(K) Flow cytometry analysis of Id1-Venus EpiSCs with or without 48-h stimulation
(L) Immunofluorescence for Id1 and Nanog in wild-type EpiSCs with or without 4
(M) Quantification of immunofluorescence signal for the cells in (L).
(N) Diagram illustrating the negative inputs of Nanog andNodal on the expression o
before Nodal becomes active.
Scale bars, 30 mm. Statistical analyses were performed using a two-tailed unpai
12 Developmental Cell 50, 1–16, August 19, 2019BMP Maintains Epiblast Identity Specifically during the
Transition between Naive and Primed States
Id1 is a target of BMP signaling (Hollnagel et al., 1999) that con-
tributes to maintenance of pluripotency in ESCs cultured in LIF +
BMP4 or LIF + FCS (Ying et al., 2003; Ying and Smith, 2003). It
has been proposed that Id1 maintains Nanog expression (Gal-
vin-Burgess et al., 2013; Romero-Lanman et al., 2012), but this
seems inconsistent with the observation that Id1 is not co-ex-
pressed with Nanog in vitro or in vivo. We reconcile our findings
with these reports by proposing that Id1 does not directly main-
tain Nanog expression, but rather increases the probability that
Nanog-low cells will return to a Nanog-high state.
Our findings also explain the previously puzzling observation
that BMP is required for maintaining pluripotency in ESCs
cultured as a mixture of naive and primed states in LIF + FCS
(Malaguti et al., 2013; Ying et al., 2003; Zhang et al., 2010) yet
is not required for maintaining pluripotency in homogenous pop-
ulations of naive cells (Graham et al., 2014;Morikawa et al., 2016;
Zhao, 2003) nor primed cells (Brons et al., 2007; Tesar et al.,
2007). Our model is also consistent with the observation that
BMP is not required for pre-implantation development (Graham
et al., 2014; Zhao, 2003) but is required to maintain pluripotency
subsequently (Di-Gregorio et al., 2007).
Much is known about the transcriptional regulators required to
escape naive pluripotency and establish a primed state (Bet-
schinger et al., 2013; Buecker et al., 2014; Galonska et al.,
2015; Leeb et al., 2014; Yang et al., 2012). For instance, the
FGF target gene Egr1 drives reorganization of enhancer binding
as cells proceed to a primed state (Galonska et al., 2015; Kumar
and Ivanova, 2015). Our data place Id1 upstream of these
factors, operating to suppress Egr1 and thus help to transiently
stabilize the naive state in the absence of Nanog. We cannot,
however, exclude the possibility that factors other than Egr1
also act downstream of Id1.
Id1 Confers Robustness to Early Development
Id1-null embryos progress through early development (Lyden
et al., 1999), and Id1-null cells can differentiate in vitro (Ro-
mero-Lanman et al., 2012), so it is clear that Id1 is not absolutely
required for early developmental transitions. Rather, we propose
that Id1 makes early development more robust by shielding
epiblast cells from pro-differentiation cues and ensuring that
cells exit naive pluripotency only once signals to sustain the
primed state are present. We confirm that Id1-null cells can pro-
ceed through early development in chimeric embryos but do so
less robustly than their wild-type neighbors.
In summary, we propose that Id1 protects epiblast identity
specifically during the transition from naive to primed states.
As embryos progress through implantation, a build-up of Nodal
simultaneously provides the environment that supports a primed
epiblast state and suppresses expression of Id1 to permit the
transition to this state.with 10 ng/mL BMP4 and/or 10 mM SB431542.
8-h stimulation with 10 ng/mL BMP4 and 10 mM SB431542.
f Id1. The results in Id1 being expressed only after Nanog is downregulated and
red Student’s t test. *p < 0.05, **p < 0.01, ***p < 0.001. See also Figure S6.
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fate to occur at the correct time and place, mechanisms must
exist to ensure that differentiation is coordinated with changes
in responsiveness to extrinsic cues. Such mechanisms ensure
canalization during early development (Waddington, 1959) and
also help to explain why it is not straightforward to control differ-
entiation of pluripotent cells in vitro simply by controlling expo-
sure to extrinsic signals.
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(A) BMP4 enables a robust transition from naive to primed pluripotency in vitro. E
absence of 10 ng/mL BMP4 for 48 h. The cells were then exposed to low levels (1 n
for their ability to retain Oct4 expression. Cells cultured in N2B27 throughout the
(B) Representative images of the samples described in (A). Act1: 1 ng/mL Activin
(C) Distribution of Oct4 expression in the samples imaged in (B), calculated by im
(D) Percentage ofOct4-positive cells observed in the samples imaged in (B), over 5 i
of the 5 experiments. Statistical analysis was performed using a one-way ANOVA f
(E) Id1 enables a robust transition from naive to primed pluripotency in vivo. E
aggregated to wild-type morulae, then transferred to pseudopregnant females. T
(F) Representative images of Id1+/+, Id1⁄, and Id1⁄ rescue chimeras, stained
(G) Quantification of ESC contribution to recovered embryos and percentage o
microscopy prior to fixation.
(H) Quantification of ESC contribution to the Oct4-positive epiblast of recovered
analysis following immunofluorescence. Statistical analysis was performed using
***p < 0.001.
See also Figure S7.
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Mus musculus: E14Ju09 mouse ESCs (129/Ola, male) Hamilton and Brickman, 2014 N/A
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Recombinant DNA
pPyCAG-NLS-GFP-EmdTM-Ires-Pac This study N/A
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of interest
This study N/A
p2loxCre Iacovino et al., 2011 Addgene Plasmid #34635
Software and Algorithms
R R Core Team http://www.R-project.org
Bioconductor Gentleman et al., 2004 http://bioconductor.org
Beadarray R package Dunning et al., 2007 http://bioconductor.org/packages/
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Animal Care and Use
Animal experiments were performed under the UK Home Office project license PEEC9E359, approved by the Animal Welfare and
Ethical Review Panel of the University of Edinburgh and within the conditions of the Animals (Scientific Procedures) Act 1986.
Cell Lines
E14Ju09 ESCs are a male wild-type clonal cell line derived in-house from E14tg2a ESCs, with a 129/Ola genetic background
(Hamilton and Brickman, 2014; Hooper et al., 1987). Id1V ESCs (male) were generated by targeting E14Ju09 ESCs with an Id1-Venus
targeting construct (Malaguti et al., 2013; Nam and Benezra, 2009). IVNR ESCs (male) were generated by targeting Id1V ESCs with a
Nanog-tagRFP targeting construct, whichwas obtained fromDr. Nicola Festuccia in Dr. Ian Chambers’ laboratory. Id1-null ESCs ande2 Developmental Cell 50, 1–16.e1–e5, August 19, 2019
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Differentiation, Developmental Cell (2019), https://doi.org/10.1016/j.devcel.2019.05.032control wild-type cells (129sv genetic background, sex unknown) were obtained from Dr. Robert Benezra (Romero-Lanman et al.,
2012). Nuclear envelope GFP-labelled Id1-null and control wild-type clonal ESC lines were obtained by random integration of a
pPyCAG-NLS-GFP-EmdTM-IRES-Pac construct. ‘‘Id1-rescue’’ clonal ESC lines were generated by random integration of a
pPyCAG-3xFlag-Id1-IRES-Pac into unlabelled Id1-null ESCs, and of a pPyCAG-3xFlag-Id1-IRES-HygroR into labelled Id1-null
ESCs. Nanog-null ESCs (TbC44cre6, male) were derived from E14tg2a ESCs and were obtained from Dr. Ian Chambers (Chambers
et al., 2007). ‘‘Nanog-rescue’’ clonal ESC lines were generated by random integration of pPyCAG-3xFlag-Nanog-IRES-Pac,
pPyCAG-3xFlag-Id1-IRES-Pac or pPyCAG-3xFlag-GFP-IRES-Pac constructs into Nanog-null ESCs. Tcf15-null ESCs (male) were
derived from E14Ju09 ESCs by replacing Tcf15 Exon 1 with a Venus-polyA transgene (CYL, SL in preparation). Inducible 3xFlag-
Id1 ESCs (male) were generated by random integration of a CAG-rtTA-IRES-Bls construct and of a tetO-3xFlag-Id1-Pgk-HygroR
construct into E14Ju09 ESCs (Malaguti et al., 2013). Inducible 3xFlag-E47-E47 ESCs (male) were generated making use of the
A2lox inducible cassette exchange cell line (Iacovino et al., 2014).
Cell Culture
Mouse embryonic stem cells were routinely maintained on gelatinised culture vessels in Glasgow Minimum Essential Medium
(GMEM, Sigma) supplemented with 10% foetal calf serum (FCS, APS), 100U/ml LIF (produced in-house), 100nM 2-mercaptoethanol
(Gibco), 1X non-essential amino acids (Gibco), 2mML-Glutamine (Gibco), 1mMSodium Pyruvate (Gibco) (‘‘LIF+FCS culture’’). 2i+LIF
culture was performed as previously described (Ying et al., 2008): cells were cultured in N2B27 medium supplemented with 1mM
PD0325901 (Axon Medchem), 3mM CHIR99021 (Axon Medchem) and 100U/ml LIF (produced in-house) on culture vessels coated
sequentially with poly-L-ornithine (Sigma) and 5mg/ml laminin (Sigma). N2B27mediumwas prepared as previously described (Pollard
et al., 2006). Its composition is a 1:1 mixture of DMEM/F12 (Gibco) and Neurobasal Medium (Gibco), supplemented with 0.5X N2
Supplement (Gibco), 0.5X B27 Supplement (Gibco), 2mM L-Glutamine (Gibco) and 100nM 2-mercaptoethanol (Gibco). Epiblast
stem cells were derived from embryonic stem cells in vitro as previously described (Guo et al., 2009), by transferring ESCs to EpiSC
culture medium on cell culture vessels coated with 7.5mg/ml fibronectin (Sigma), and passaging them every 1-2 days. EpiSCs were
used for experimentation between passages 10 and 20. EpiSC culturemedium composition is as previously described (Osorno et al.,
2012): N2B27 medium supplemented with 10ng/ml Fgf2 (R&D) and 20ng/ml Activin A (R&D). EpiLC differentiation was performed as
previously described (Hayashi et al., 2011). Briefly, 2i+LIF cells were plated on cell culture vessels coated with 7.5mg/ml fibronectin
(Sigma) in EpiLC medium at a density of 2.5x104 cells/cm2. EpiLC medium consists of N2B27 medium supplemented with 10ng/ml
Fgf2 (R&D), 20ng/ml Activin A (R&D) and 1% KSR (Gibco). Medium was changed 24h after plating.Cells were cultured at 37C in
5% CO2.
METHOD DETAILS
Plasmid Preparation
pPyCAG overexpression plasmids and p2lox cassette exchange plasmids were generated through conventional restriction enzyme-
mediated ligation of DNA fragments flanked by convenient restriction sites. The DNA sequences of genes of interest were amplified
from mouse ESC cDNA. The nuclear envelope GFP overexpression construct encodes a fusion protein comprising an N-terminal
NLS, followed by GFP, and a C-terminal sequence consisting of the transmembrane domain of the inner nuclear membrane protein
emerin (structure: pPyCAG-NLS-GFP-EmdTM-IRES-Pac).
Transfection
Overexpression plasmids were lipofected into cells using Lipofectamine 3000 reagent (Invitrogen), following the manufacturer’s in-
structions. p2lox cassette exchange were nucleofected into A2loxCre parental cells as previously described (Iacovino et al., 2014).
Embryo Collection
Pre- and peri-implantation embryos were obtained by flushing uteri with a large-bore blunted needle in M2 medium (Sigma). Post-
implantation embryos were dissected at 5.5 and 6.5 d.p.c. in M2medium. The sex of embryos used in this study was not determined.
Chimaera Generation
F1 female mice were superovulated (100 IU/ml PMSG, ProSpec, and 100 IU/ml HCG, Intervet, intraperitoneal injections 48h apart)
and crossed with wild-type stud male mice. Pregnant mice were culled at 2.5 d.p.c. by cervical dislocation, ovaries with oviducts
were dissected and collected in pre-warmed M2 medium. Oviducts were flushed using PBS and a 20-gauge needle attached to a
1ml syringe and filled with PB1. 2.5 d.p.c. embryos were collected and washed in PB1, the zona pellucida was removed using acidic
Tyrode’s solution (Sigma), and transferred to a plate with incisions where one clump of 8-15 cells were added to each embryo.
Embryos were then incubated at 37C in 5% CO2 for 24h prior to transfer to pseudopregnant recipients, or for up to 72h for assess-
ment of pre-implantation chimaerism. Blastocysts were selected and collected to be transferred into the uterus of a pseudopregnant
CD-1 female. Embryos were dissected at 6.5 d.p.c. in M2 medium and observed for chimeric ESC contribution under an Olympus
IX51 microscope, prior to fixation and immunostaining.Developmental Cell 50, 1–16.e1–e5, August 19, 2019 e3
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Embryos were fixed with 4% formaldehyde/PBS/0.1% Triton X-100 (Sigma) for 10 (pre-implantation), 20 (peri-implantation) or 30
(post-implantation) minutes and quenched with 50mM ammonium chloride. Cellular permeabilization was carried out for 10 min in
PBS/0.1% Triton X-100. The embryos were incubated in primary antibody in 3% donkey serum/PBS/0.1% Triton X-100 overnight,
and subjected to 3 washes in PBS/0.1% Triton X-100. Secondary antibodies were applied subsequently for 2h to overnight, followed
by 3 washes in PBS/0.1% Triton X-100. Embryos were then stained with DAPI (Biotium), mounted in PBS droplets covered with min-
eral oil in ‘‘microscope rings’’, and imaged on a Leica SP8 confocal microscope. Alternatively, following staining, chimaeric embryos
requiring immunostaining quantification were dehydrated in methanol series in PBS/0.1% Triton X-100, clarified in 50% methanol/
50% BABB (benzyl alcohol:benzyl benzoate 1:2 ratio, Alfa Aesar and Sigma), transferred into 100% BABB in glass capillaries and
imaged on a Leica SP8 confocal microscope.
Cell Immunofluorescence and Confocal Microscopy
Cells for immunofluorescence were cultured on flamed glass coverslips coated with 7.5mg/ml fibronectin (for adherent culture), or
cytospun onto polysine adhesion slides (Thermo Fisher) using a Shandon Cytospin 3 centrifuge (for sorted samples in suspension).
They were fixed in 4% formaldehyde/PBS, quenched with 50mM ammonium chloride, blocked in 3% donkey serum and 0.1% Triton
X-100. Cells were then incubated with primary antibody for 3 h at room temperature, washed 3 times with PBS, incubated with sec-
ondary antibody and/or 100ng/ml DAPI for 1h at room temperature, washed 3 times with PBS, mounted in ProLong Gold Antifade
Mountant (Molecular Probes), and imaged on a Leica SP8 confocal microscope. Where recommended by antibody manufacturers,
a methanol permeabilisation step was included prior to blocking.
Immunofluorescence Quantification
Nuclear immunofluorescence signal was quantified using nuclear segmentation based on nuclear envelope staining or DAPI, as well
as manual editing of segmentation results, making use of the NesSys software described in (Blin et al., 2018).
Gene Expression Analysis
Total RNA was extracted from cells making use of the Absolutely RNA Miniprep Kit (Stratagene). 300ng total RNA were reverse
transcribed into cDNA making use of M-MLV Reverse Transcriptase (Invitrogen). qRT-PCR was performed using the Universal
ProbeLibrary system (Roche) with a Lightcycler 480 II instrument. Expression data are presented relative to the geometric mean
of the housekeeping genes Sdha, Tbp and Ywhaz. The sequences of the primers used in this study are listed in Table S2.
Flow Cytometry
Cells were dissociated into single cell suspensions in ice-cold PBS+10% FCS, in the presence of either 100ng/ml DAPI or 1mg/ml
propidium iodide to stain dead cells. Analysis of fluorescence was performed on a BD FACSCalibur. Cell sorting was performed
on a BD FACSAria.
Clonal Self-renewal Assays and Alkaline Phosphatase Staining
Cells were plated 10-30 cells/cm2 in media as indicated in figure legends, and media were changed every other day. After 7 days,
alkaline phosphatase staining was performed using the Leukocyte Alkaline Phosphatase Kit (Sigma).
Transcriptome (Microarray) Analyses
Sample preparation for microarrays was performed as previously described (Davies et al., 2013). 100 ng of total RNA were reverse
transcribed into double-stranded cDNA and transcribed/amplified into biotin labelled cRNA using an Illumina TotalPrep RNA
Amplification Kit (Ambion). Labelled RNA was submitted to the WTCRF MRC Human Genetics Unit (University of Edinburgh) for
further processing. cRNA quality was checked using an Agilent 2100 Bioanalyser and hybridisation performed on an MouseWG-6
v2 BeadChip (Illumina). Raw data were processed in R using the beadarray (Dunning et al., 2007) and limma (Wettenhall and
Smyth, 2004) packages from the Bioconductor suite (Gentleman et al., 2004). Briefly, expression data were quantile-normalised
and log2-transformed before assessing differential expression with the limma algorithms. Principal component analysis was per-
formed using the prcomp() function in the core R stats package. Quantile-normalised microarray data are available in Table S1.
Western Blotting
Cells were lysed in RIPA buffer + 1X PMSF (Alpha Diagnostics). 20mg protein lysates were run on 4%-12% NuPage Bis-Tris Gel
(Novex) and transferred onto Amersham Hybond ECL Nitrocellulose Membrane (GE Healthcare). Membranes were blocked in 5%
Amersham ECL Prime Blocking Agent (GE Healthcare) + 0.1% Tween 20 (Sigma) in PBS. Membranes were incubated in primary
antibody overnight at 4C, washed 3 times in PBS + 0.1% Tween 20, incubated in HRP-conjugated secondary antibody for 1 h at
room temperature and washed 3 times in PBS + 0.1% Tween 20. The membrane was incubated in Amersham ECLWestern Blotting
Detection Reagent (GE Healthcare) or Amersham ECL PrimeWestern Blotting Detection Reagent (GE Healthcare), depending on the
expected strength of signal. The membranes were used to expose Amersham Hyperfilm ECL (GE Healthcare), and films were
developed using a Konica SRX-101A Medical Film Processor.e4 Developmental Cell 50, 1–16.e1–e5, August 19, 2019
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Genomic DNAwas extracted frommouse ESCs using the DNeasy Blood and Tissue kit (Qiagen). Southern blotting was performed as
previously described (Southern, 1975). Briefly, 5mg genomic DNA was digested with 100U BamHI-HF (NEB) overnight at 37C, in the
presence of 2.5mM spermidine (Sigma). The DNA was ethanol-precipitated, resuspended in 20ml dH2O, and run on a 0.8% w/v
agarose/TAE gel. l DNA-HindIII digest was loaded as a size marker. The gel was placed in denaturing solution (aqueous solution
of 86.77g/l sodium chloride + 20g/l sodium hydroxide) for 40 minutes at room temperature, and neutralising solution (aqueous
solution of 116.8g/l sodium chloride, 121.1g/l Tris base, pH8.0) for 40 minutes at room temperature. DNA was transferred onto a
positively charged nylon membrane (Roche) by capillary transfer of 20X SSC buffer (aqueous solution of 175.2g/l sodium chloride +
88.2g/l Tris base, pH7.4) for 48 h at room temperature. Themembrane was then baked for 1 h at 120C, rinsed in 2X SSC, and placed
in a glass hybridisation bottle with PerfectHyb Plus (Sigma) hybridisation buffer at 65C for 1 h. Probes were generated by PCR ampli-
fication of sequences of interest (Table S2), and labelled with [a-32P]dCTP using the Amersham Rediprime II DNA Labelling System
(GE Healthcare), alongside the control l HindIII DNA to detect the size marker. 500ml sonicated herring sperm DNA (Sigma) and the
probes were added to the hybridisation bottle overnight at 65C. The hybridisation solution was removed, and the membrane was
washed twice for 15 minutes in 2X SSC+0.1% SDS, and once for 30 minutes in 0.5X SSC+0.1% SDS. The membrane was used to
expose Amersham Hyperfilm ECL (GE Healthcare), and films were developed using a Konica SRX-101A Medical Film Processor.
QUANTIFICATION AND STATISTICAL ANALYSIS
Definition of statistical significance and size of n is indicated in Figure Legends. Statistical analysis methods include two-tailed
Student’s t-test for comparison of two samples, one-way ANOVA followed by Tukey’s multiple comparison test for comparison of
more than two samples with normal distributions, Kruskal-Wallis test followed by Dunn’s multiple comparison test for comparison
of more than two samples with non-normal distributions, and empirical Bayes moderated t-statistics for linear model fit contrasts
for microarray data, with p-values adjusted for multiple testing correction using the Benjamini & Hochberg method.
DATA AND CODE AVAILABILITY
The accession number for the raw and normalized microarray data reported in this paper is GEO: GSE108226.Developmental Cell 50, 1–16.e1–e5, August 19, 2019 e5
